Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN55,5455,5-1,49
Msft214,96214,97-0,19
Nokia3,2813,3090,41
IBM124,42124,43-0,14
Daimler AG56,7756,78-1,25
PFE40,3140,32-1,20
03.12.2020 17:36:01
Indexy online
AD Index online
select
AD Index online
 

  • 03.12.2020 17:29:56
Biotage (BIOT.ST, Stockholm)
Poslední obchod Změna (%) Změna (SEK) Objem obchodů (SEK)
137,80 0,80 1,10 8 902 312
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 03.12.2020
Popis společnosti
Obecné informace
Název společnostiBiotage AB
TickerBIOT
Kmenové akcie:Ordinary Shares
RICBIOT.ST
ISINSE0000454746
Poslední známé roční výsledky31.12.2019
Poslední známé čtvrtletní výsledky30.09.2020
Počet zaměstnanců k 30.09.2020 466
Akcie v oběhu k 30.09.2020 65 201 784
MěnaSEK
Kontaktní informace
UliceVimpelgatan 5
MěstoUPPSALA
PSČ753 18
ZeměSweden
Kontatní osobaTomas Blomquist
Funkce kontaktní osobyPresident, Chief Executive Officer
Telefon4 618 565 900
Fax4618591922
Kontatní telefon46 705 230 163

Business Summary: Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage’s offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Company’s offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.
Financial Summary: BRIEF: For the nine months ended 30 September 2020, BiotageAB revenues decreased 2% to SEK794.2M. Net income decreased22% to SEK130.9M. Revenues reflect a decrease in demand forthe Company's products and services due to unfavorablemarket conditions. Net income also reflects Administrativeexpenses increase of 47% to SEK55.3M (expense), Otheroperating income increase from SEK8.7M (income) to SEK3.3M(expense).
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Medical Diagnostic & Testing Equipment
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICS2007Electromedical Apparatus Mfg
NAICS2007Analytical Laboratory Instrument Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Analytical Laboratory Instrument Manufacturing
SICElectromedical Equipment
SICAnalytical Instruments



  • Poslední aktualizace: 03.12.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the BoardTorben Joergensen6807.11.201927.04.2006
President, Chief Executive OfficerTomas Blomquist5006.11.201906.11.2019
Chief Financial OfficerAnnette Colin5501.04.202001.04.2020
Executive Vice President of Global MarketingRikke Rytter5301.01.2017
Executive Vice President - OperationsAnders Wikstrom47
Chief Scientific OfficerSteve Jordan67
Global Human Resources DirectorCecilia Hallner48
Chief Legal OfficerLars Backman5901.04.2020